To begin with, Charles River Laboratories International seems to have a respectable ROE. And on comparing with the industry, we found that the the average industry ROE is similar at 12%. This ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Charles River Labs (CRL – Research Report) today and set a price ...

Charles River Laboratories International is cutting over 600 jobs, citing softening demand from pharmaceutical clients.

Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...

Charles River Laboratories has multiple sites in the Triangle area, but its local workforce has gotten smaller.

After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first ...

As part of the DanubeNeuro program, Charles River and CEBINA will accelerate innovative approaches to treating neurodegenerative diseases Charles River Laboratories International, Inc. (NYSE: CRL ...

Charles River Laboratories (NYSE: CRL) is reducing its workforce by about 3% as part of broader cost-cutting efforts. The ...

A nonprofit group recently ran a billboard campaign targeting the Western Michigan University Homer Stryker M.D. School of Medicine.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $218.3, with a ...